Orthofix Medical Inc. (NASDAQ:OFIX) Insider Sells $71,164.20 in Stock

Orthofix Medical Inc. (NASDAQ:OFIX) insider Lucas Vitale sold 4,287 shares of Orthofix Medical stock in a transaction that occurred on Tuesday, March 18th. The shares were sold at an average price of $16.60, for a total transaction of $71,164.20. Following the transaction, the insider now directly owns 135,317 shares in the company, valued at approximately $2,246,262.20. This trade represents a 3.07 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink.

Orthofix Medical Price Performance

OFIX opened at $16.63 on Friday. Orthofix Medical Inc. has a twelve month low of $12.08 and a twelve month high of $20.73. The firm has a market cap of $648.94 million, a price-to-earnings ratio of -5.31 and a beta of 1.06. The company has a current ratio of 2.39, a quick ratio of 1.11 and a debt-to-equity ratio of 0.25. The company has a fifty day simple moving average of $17.77 and a 200 day simple moving average of $17.37.

Analyst Ratings Changes

Several research firms recently weighed in on OFIX. StockNews.com upgraded shares of Orthofix Medical from a “hold” rating to a “buy” rating in a report on Tuesday, February 25th. Canaccord Genuity Group restated a “buy” rating and set a $24.00 price objective on shares of Orthofix Medical in a research note on Wednesday, February 26th. Finally, Roth Mkm reaffirmed a “buy” rating and issued a $22.00 target price on shares of Orthofix Medical in a research report on Wednesday, February 26th. One investment analyst has rated the stock with a hold rating and five have assigned a buy rating to the company’s stock. According to data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $23.33.

Institutional Trading of Orthofix Medical

Several large investors have recently modified their holdings of the business. GSA Capital Partners LLP purchased a new position in Orthofix Medical in the third quarter valued at about $312,000. Victory Capital Management Inc. grew its position in shares of Orthofix Medical by 3.3% during the third quarter. Victory Capital Management Inc. now owns 64,807 shares of the medical device company’s stock worth $1,012,000 after buying an additional 2,074 shares in the last quarter. Quest Partners LLC increased its stake in shares of Orthofix Medical by 187.1% in the third quarter. Quest Partners LLC now owns 13,908 shares of the medical device company’s stock worth $217,000 after buying an additional 9,063 shares during the last quarter. Connor Clark & Lunn Investment Management Ltd. raised its holdings in Orthofix Medical by 17.0% in the third quarter. Connor Clark & Lunn Investment Management Ltd. now owns 34,632 shares of the medical device company’s stock valued at $541,000 after acquiring an additional 5,039 shares in the last quarter. Finally, Charles Schwab Investment Management Inc. boosted its stake in Orthofix Medical by 14.0% during the 3rd quarter. Charles Schwab Investment Management Inc. now owns 324,807 shares of the medical device company’s stock valued at $5,073,000 after acquiring an additional 39,901 shares during the last quarter. 89.76% of the stock is currently owned by institutional investors and hedge funds.

About Orthofix Medical

Orthofix Medical Inc operates as a spine and orthopedics company in the United States, Italy, Germany, the United Kingdom, France, Brazil, and internationally. It operates through two segments, Global Spine and Global Orthopedics. The Global Spine segment manufactures and distributes bone growth stimulator devices for enhance of bone fusion, including adjunctive and noninvasive treatment of cervical and lumbar spine, as well as a therapeutic treatment for non-spine; designs, develops, and markets a portfolio of motion preservation and fixation implant products, which are used in surgical procedures of the spine; and offers biological products, such as fiber-based and particulate demineralized bone matrices, cellular bone allografts, collagen ceramic matrices, and synthetic bone void fillers, and tissue forms, which allow physicians to treat various spinal and orthopedic conditions.